Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

DENTSPLY SIRONA (NASDAQ:XRAY - Get Rating) was downgraded by stock analysts at StockNews.com from a "buy" rating to a "hold" rating in a research report issued to clients and investors on Monday.

Several other research firms have also commented on XRAY. The Goldman Sachs Group dropped their price target on shares of DENTSPLY SIRONA from $42.00 to $41.00 and set a "neutral" rating on the stock in a research report on Thursday, July 21st. Robert W. Baird cut DENTSPLY SIRONA from an "outperform" rating to a "neutral" rating and dropped their target price for the company from $67.00 to $48.00 in a research report on Tuesday, April 19th. UBS Group raised DENTSPLY SIRONA from a "neutral" rating to a "buy" rating and reduced their price target for the stock from $58.00 to $47.00 in a report on Wednesday, June 1st. Barrington Research dropped their price objective on DENTSPLY SIRONA from $53.00 to $51.00 in a report on Wednesday, May 11th. Finally, William Blair downgraded DENTSPLY SIRONA from a "market perform" rating to an "underperform" rating in a research note on Friday, August 5th. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $48.11.DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY traded down $0.05 during trading hours on Monday, reaching $37.60. The company had a trading volume of 1,144,916 shares, compared to its average volume of 2,139,154. The firm has a market cap of $8.10 billion, a PE ratio of 22.25, a price-to-earnings-growth ratio of 3.05 and a beta of 0.91. DENTSPLY SIRONA has a 1-year low of $33.78 and a 1-year high of $63.10. The business's 50 day moving average price is $36.20 and its 200-day moving average price is $43.16. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.45 and a quick ratio of 1.03. Hedge Funds Weigh In On DENTSPLY SIRONA

Hedge funds and other institutional investors have recently modified their holdings of the business. SOA Wealth Advisors LLC. lifted its stake in DENTSPLY SIRONA by 26,666.7% in the 1st quarter. SOA Wealth Advisors LLC. now owns 803 shares of the medical instruments supplier's stock worth $39,000 after purchasing an additional 800 shares in the last quarter. Van ECK Associates Corp acquired a new position in DENTSPLY SIRONA during the second quarter worth $41,000. Parkside Financial Bank & Trust grew its holdings in DENTSPLY SIRONA by 33.8% in the 2nd quarter. Parkside Financial Bank & Trust now owns 1,224 shares of the medical instruments supplier's stock valued at $43,000 after buying an additional 309 shares in the last quarter. Dixon Hughes Goodman Wealth Advisors LLC purchased a new stake in DENTSPLY SIRONA in the 1st quarter valued at $79,000. Finally, Covestor Ltd purchased a new position in shares of DENTSPLY SIRONA during the 4th quarter worth $90,000. 94.79% of the stock is owned by hedge funds and other institutional investors. About DENTSPLY SIRONA (Get Rating)

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.Featured StoriesGet a free copy of the StockNews.com research report on DENTSPLY SIRONA (XRAY)The Five Hottest Calls From The Q2 Earnings Season Here is a Simple 4 Stock Portfolio that Can Outperform the MarketIs AMC Entertainment Pulling a Fast One on the APEs?Here’s How the Inflation Reduction Act Energizes Power StockThe Institutions Trim Holdings Of High-Yielding Foot Locker, Inc

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Strategy for maintaining your portfolio value while still making withdrawals to pay your life expenses. And most importantly, avoiding big losses.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.